Latest Updates
-
Eat, Celebrate, Repeat: 6 Ayurvedic Tips To Keep Your Digestion Happy This Navratri 2026 -
Breast Cancer Awareness Month 2026: Expert Explains The Emotional Toll Of Breast Cancer -
Navratri 2026 Food Hopping In Delhi NCR: 7 Places To Explore For A Taste Of Festive Flavours -
Why Casual Games Are Perfect for Quick Online Play -
World Menopause Day 2026: Theme, Significance And What Research Reveals About Menopause In India -
Navratri Day 8: Maa Mahagauri Puja, Colour, Rituals And Significance -
Dussehra 2026: The Difference Between Vijayadashami And Ravana Dahan -
Veteran Musician Deva Dies At 75: Life And Legacy Of Thenisai Thendral -
Navratri Fasting Diet: How To Stay Energised And Full Through The Day -
Kavya Maran Wedding In Greece? Date, Venue, and What Is Confirmed
Diabetes Drug May Cut Heart, Kidney Disease Risk
A drug that lowers blood sugar levels for people with Type 2 diabetes may also significantly help reduce the risk of both cardiovascular and kidney disease, researchers claimed.
A drug that lowers blood sugar levels for people with Type 2 diabetes may also significantly help reduce the risk of both cardiovascular and kidney disease, researchers claimed.
Type 2 diabetes, which affects around 450 million people worldwide, also increases the risks of stroke and heart attack.

The findings, published in the New England Journal of Medicine, showed that the drug -- canagliflozin -- reduced the overall risk of cardiovascular disease by 14 per cent and reduced the risk of heart failure hospitalisation by 33 per cent.
It was also shown to have a significant impact on the progression of renal disease, as the patients were 40 per cent less likely to suffer serious kidney decline, the researchers said in the paper published in the New England Journal of Medicine.
"Coronary heart disease is the biggest killer by far for people with Type 2 diabetes. Our findings suggest that not only does canagliflozin significantly reduce the risk of heart disease, it also has many other benefits too. We found it also reduced blood pressure and led to weight loss," said Bruce Neal, Professor at The George Institute for Global Health in New South Wales, Australia.
Canagliflozin, known as a SGLT2 inhibitor, is a relatively new type of drug that works by blocking the body's reabsorption of sugar or glucose.
This results in more glucose being released in urine and a drop in glucose levels. Most other diabetes drugs work by managing insulin levels.
"This really is a game changer in the treatment of Type 2 diabetes. It not only reduces the risk of heart disease, it also provides real protection against kidney decline which affects many people with diabetes," added Vlado Perkovic, Professor and Executive Director at The George Institute for Global Health.

For the study, the team analysed more than 10,000 patients in 30 countries.
With Inputs From IANS
Disclaimer: The information provided in this article is for general informational and educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or a qualified healthcare provider with any questions you may have regarding a medical condition.



Click it and Unblock the Notifications
